CIBC World Markets’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $439K | Sell |
7,985
-687
| -8% | -$37.8K | ﹤0.01% | 853 |
|
|
2025
Q1 | $613K | Buy |
8,672
+57
| +0.7% | +$4.03K | ﹤0.01% | 901 |
|
|
2024
Q4 | $566K | Sell |
8,615
-2,450
| -22% | -$161K | ﹤0.01% | 694 |
|
|
2024
Q3 | $778K | Buy |
11,065
+832
| +8% | +$58.5K | 0.01% | 637 |
|
|
2024
Q2 | $842K | Sell |
10,233
-11,952
| -54% | -$984K | 0.01% | 604 |
|
|
2024
Q1 | $1.94M | Sell |
22,185
-248,057
| -92% | -$21.7M | 0.01% | 512 |
|
|
2023
Q4 | $26.1M | Buy |
+270,242
| New | +$26.1M | 0.14% | 114 |
|
|
2023
Q2 | – | Sell |
-34,000
| Closed | -$3.31M | – | 584 |
|
|
2023
Q1 | $3.31M | Hold |
34,000
| – | – | 0.05% | 250 |
|
|
2022
Q4 | $3.52M | Hold |
34,000
| – | – | 0.02% | 390 |
|
|
2022
Q3 | $2.88M | Buy |
+34,000
| New | +$2.88M | 0.04% | 224 |
|
|
2022
Q1 | – | Sell |
-30,000
| Closed | -$2.65M | – | 615 |
|
|
2021
Q4 | $2.65M | Buy |
+30,000
| New | +$2.65M | 0.01% | 356 |
|
|
2020
Q4 | – | Sell |
-10,091
| Closed | -$768K | – | 631 |
|
|
2020
Q3 | $768K | Sell |
10,091
-1,612
| -14% | -$123K | 0.01% | 506 |
|
|
2020
Q2 | $1.44M | Sell |
11,703
-3,144
| -21% | -$388K | 0.02% | 446 |
|
|
2020
Q1 | $1.26M | Buy |
14,847
+191
| +1% | +$16.1K | 0.02% | 404 |
|
|
2019
Q4 | $1.24M | Buy |
14,656
+8,263
| +129% | +$699K | 0.01% | 620 |
|
|
2019
Q3 | $431K | Buy |
+6,393
| New | +$431K | ﹤0.01% | 561 |
|
|
2018
Q4 | – | Sell |
-4,288
| Closed | -$416K | – | 567 |
|
|
2018
Q3 | $416K | Buy |
+4,288
| New | +$416K | ﹤0.01% | 576 |
|
|
2018
Q1 | – | Sell |
-13,034
| Closed | -$1.16M | – | 607 |
|
|
2017
Q4 | $1.16M | Sell |
13,034
-20
| -0.2% | -$1.78K | 0.01% | 545 |
|
|
2017
Q3 | $1.22M | Buy |
13,054
+104
| +0.8% | +$9.68K | 0.01% | 506 |
|
|
2017
Q2 | $1.18M | Buy |
+12,950
| New | +$1.18M | 0.01% | 530 |
|
|
2016
Q4 | – | Sell |
-3,308
| Closed | -$306K | – | 555 |
|
|
2016
Q3 | $306K | Sell |
3,308
-7,393
| -69% | -$684K | 0.01% | 202 |
|
|
2016
Q2 | $833K | Buy |
10,701
+1,011
| +10% | +$78.7K | 0.02% | 145 |
|
|
2016
Q1 | $799K | Sell |
9,690
-3,681
| -28% | -$304K | 0.02% | 132 |
|
|
2015
Q4 | $1.4M | Buy |
13,371
+2,224
| +20% | +$233K | 0.03% | 142 |
|
|
2015
Q3 | $1.17M | Buy |
+11,147
| New | +$1.17M | 0.03% | 135 |
|